|
1
|
Hazlett LD: Corneal response to
Pseudomonas aeruginosa infection. Prog Retin Eye Res. 23:1–30.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wilhelmus KR: Review of clinical
experience with microbial keratitis associated with contact lenses.
CLAO J. 13:211–214. 1987.PubMed/NCBI
|
|
3
|
Engel LS, Callegan MC, Hobden JA, Reidy
JJ, Hill JM and O'Callaghan RJ: Effectiveness of specific
antibiotic/steroid combinations for therapy of experimental
Pseudomonas aeruginosa keratitis. Curr Eye Res. 14:229–234. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hazlett LD: Pathogenic mechanisms of P.
aeruginosa keratitis: a review of the role of T cells, Langerhans
cells, PMN, and cytokines. DNA Cell Biol. 21:383–390. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kernacki KA, Goebel DJ, Poosch MS and
Hazlett LD: Early cytokine and chemokine gene expression during
Pseudomonas aeruginosa corneal infection in mice. Infect Immun.
66:376–379. 1998.PubMed/NCBI
|
|
6
|
Xue ML, Thakur A and Willcox M: Gene
expression of pro-inflammatory cytokines and chemokines in mouse
eye infected with Pseudomonas aeruginosa. Clin Experiment
Ophthalmol. 30:196–199. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eisenbarth SC and Flavell RA: Innate
instruction of adaptive immunity revisited: the inflammasome. EMBO
Mol Med. 1:92–98. 2009. View Article : Google Scholar
|
|
8
|
Shaw PJ, Lamkanfi M and Kanneganti TD:
NOD-like receptor (NLR) signaling beyond the inflammasome. Eur J
Immunol. 40:624–627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang SK, Gu Z and Brenner MB:
Fibroblast-like synoviocytes in inflammatory arthritis pathology:
the emerging role of cadherin-11. Immunol Rev. 233:256–266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martinon F, Gaide O, Pétrilli V, Mayor A
and Tschopp J: NALP inflammasomes: a central role in innate
immunity. Semin Immunopathol. 29:213–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davis BK, Roberts RA, Huang MT, Willingham
SB, Conti BJ, Brickey WJ, Barker BR, Kwan M, Taxman DJ,
Accavitti-Loper MA, et al: Cutting edge: NLRC5-dependent activation
of the inflammasome. J Immunol. 186:1333–1337. 2011. View Article : Google Scholar
|
|
12
|
Lamkanfi M and Dixit VM: Modulation of
inflammasome pathways by bacterial and viral pathogens. J Immunol.
187:597–602. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masters SL, Gerlic M, Metcalf D, Preston
S, Pellegrini M, O'Donnell JA, McArthur K, Baldwin TM, Chevrier S,
Nowell CJ, et al: NLRP1 inflammasome activation induces pyroptosis
of hematopoietic progenitor cells. Immunity. 37:1009–1023. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minkiewicz J, de Rivero Vaccari JP and
Keane RW: Human astrocytes express a novel NLRP2 inflammasome.
Glia. 61:1113–1121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Duewell P, Kono H, Rayner KJ, Sirois CM,
Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr
M, et al: NLRP3 inflammasomes are required for atherogenesis and
activated by cholesterol crystals. Nature. 464:1357–1361. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sutterwala FS, Mijares LA, Li L, Ogura Y,
Kazmierczak BI and Flavell RA: Immune recognition of Pseudomonas
aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med.
204:3235–3245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Elinav E, Strowig T, Kau AL, Henao-Mejia
J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon
JI, et al: NLRP6 inflammasome regulates colonic microbial ecology
and risk for colitis. Cell. 145:745–757. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khare S, Dorfleutner A, Bryan NB, Yun C,
Radian AD, de Almeida L, Rojanasakul Y and Stehlik C: An
NLRP7-containing inflammasome mediates recognition of microbial
lipopeptides in human macrophages. Immunity. 36:464–476. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Conti BJ, Davis BK, Zhang J, O'connor W
Jr, Williams KL and Ting JP: CATERPILLER 16.2 (CLR16.2), a novel
NBD/LRR family member that negatively regulates T cell function. J
Biol Chem. 280:18375–18385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schneider M, Zimmermann AG, Roberts RA,
Zhang L, Swanson KV, Wen H, Davis BK, Allen IC, Holl EK, Ye Z, et
al: The innate immune sensor NLRC3 attenuates toll-like receptor
signaling via modification of the signaling adaptor TRAF6 and
transcription factor NF-κB. Nat Immunol. 13:823–831. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Mo J, Swanson KV, Wen H,
Petrucelli A, Gregory SM, Zhang Z, Schneider M, Jiang Y, Fitzgerald
KA, et al: NLRC3, a member of the NLR family of proteins, is a
negative regulator of innate immune signaling induced by the DNA
sensor STING. Immunity. 40:329–341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang K, Wu M, Li M, Li D, Peng A, Nie X,
Sun M, Wang J, Wu Y, Deng Q, et al: miR-155 suppresses bacterial
clearance in Pseudomonas aeruginosa-induced keratitis by targeting
Rheb. J Infect Dis. 210:89–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang X, Barrett RP, McClellan SA and
Hazlett LD: Silencing toll-like receptor-9 in Pseudomonas
aeruginosa keratitis. Invest Ophthalmol Vis Sci. 46:4209–4216.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hazlett LD, McClellan S, Kwon B and
Barrett R: Increased severity of Pseudomonas aeruginosa corneal
infection in strains of mice designated as Th1 versus Th2
responsive. Invest Ophthalmol Vis Sci. 41:805–810. 2000.PubMed/NCBI
|
|
25
|
Chen K, Yin L, Nie X, Deng Q, Wu Y, Zhu M,
Li D, Li M, Wu M and Huang X: β-Catenin promotes host resistance
against Pseudomonas aeruginosa keratitis. J Infect. 67:584–594.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karin M and Lin A: NF-kappaB at the
crossroads of life and death. Nat Immunol. 3:221–227. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun Y, Karmakar M, Roy S, Ramadan RT,
Williams SR, Howell S, Shive CL, Han Y, Stopford CM, Rietsch A, et
al: TLR4 and TLR5 on corneal macrophages regulate Pseudomonas
aeruginosa keratitis by signaling through MyD88-dependent and
-independent pathways. J Immunol. 185:4272–4283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luftig M, Prinarakis E, Yasui T,
Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh
WC, Li X, et al: Epstein-Barr virus latent membrane protein 1
activation of NF-kappaB through IRAK1 and TRAF6. Proc Natl Acad Sci
USA. 100:15595–15600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suzuki N, Suzuki S, Duncan GS, Millar DG,
Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, et al: Severe
impairment of interleukin-1 and toll-like receptor signalling in
mice lacking IRAK-4. Nature. 416:750–756. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao Z, Xiong J, Takeuchi M, Kurama T and
Goeddel DV: TRAF6 is a signal transducer for interleukin-1. Nature.
383:443–446. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liesegang TJ: Contact lens-related
microbial keratitis: part I: epidemiology. Cornea. 16:125–131.
1997.PubMed/NCBI
|
|
32
|
Kowalski RP, Romanowski EG, Mah FS, Shanks
RM and Gordon YJ: Topical levofloxacin 1.5% overcomes in vitro
resistance in rabbit keratitis models. Acta Ophthalmol.
88:e120–e125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McCormick C, Caballero A, Tang A, Balzli
C, Song J and O'Callaghan R: Effectiveness of a new tobramycin
(0.3%) and dexamethasone (0.05%) formulation in the treatment of
experimental Pseudomonas keratitis. Curr Med Res Opin.
24:1569–1575. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mohammadpour M, Mohajernezhadfard Z,
Khodabande A and Vahedi P: Antibiotic susceptibility patterns of
Pseudomonas corneal ulcers in contact lens wearers. Middle East Afr
J Ophthalmol. 18:228–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cowell BA, Willcox MD, Hobden JA,
Schneider RP, Tout S and Hazlett LD: An ocular strain of
Pseudomonas aeruginosa is inflammatory but not virulent in the
scarified mouse model. Exp Eye Res. 67:347–356. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Allen IC, Wilson JE, Schneider M, Lich JD,
Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth
HH, et al: NLRP12 suppresses colon inflammation and tumorigenesis
through the negative regulation of noncanonical NF-κB signaling.
Immunity. 36:742–754. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ye Z, Lich JD, Moore CB, Duncan JA,
Williams KL and Ting JP: ATP binding by monarch-1/NLRP12 is
critical for its inhibitory function. Mol Cell Biol. 28:1841–1850.
2008. View Article : Google Scholar :
|
|
38
|
Allen IC, Moore CB, Schneider M, Lei Y,
Davis BK, Scull MA, Gris D, Roney KE, Zimmermann AG, Bowzard JB, et
al: NLRX1 protein attenuates inflammatory responses to infection by
interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.
Immunity. 34:854–865. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xia X, Cui J, Wang HY, Zhu L, Matsueda S,
Wang Q, Yang X, Hong J, Songyang Z, Chen ZJ, et al: NLRX1
negatively regulates TLR-induced NF-κB signaling by targeting TRAF6
and IKK. Immunity. 34:843–853. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Deng Q, Wang Y, Zhang Y, Li M, Li D, Huang
X, Wu Y, Pu J and Wu M: Pseudomonas aeruginosa triggers macrophage
autophagy to escape intracellular killing by activation of the
NLRP3 inflammasome. Infect Immun. 84:56–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gottipati S, Rao NL and Fung-Leung WP:
IRAK1: a critical signaling mediator of innate immunity. Cell
Signal. 20:269–276. 2008. View Article : Google Scholar
|
